You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 38 No. 3, March 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Collagen Localization in Normal and Fibrotic Human Skeletal Muscle

Marguerite Foidart, MD; Jean-Michel Foidart, MD; W. King Engel, MD

Arch Neurol. 1981;38(3):152-157.


Abstract

• The distribution of types I to IV collagen, types I and III p-N collagen, and fibronectin in human skeletal muscle was studied by immunofluorescence using purified antibodies to those proteins. In normal muscle, types I and III collagen, types I and III p-N collagen, and fibronectin were localized in the endomysium and perimysium. Type IV collagen was restricted to basement membrane. Type II collagen was not present. In Duchenne's muscular dystrophy and dermatomyositis/polymyositis (DM/PM), the prominently increased endomysial and perimysial fibrosis consisted of types I and III collagen, types I and III p-N collagen, and fibronectin. In DM/PM, thickening of the walls of perimysial venular and arteriolar vessels was associated with accumulation of types I and III collagen, types I and III p-N collagen, and fibronectin, as well as type IV collagen. There was no disease-specific accumulation of collagen, p-N collagen, or fibronectin.



Author Affiliations

From the Medical Neurology Branch (Drs M. Foidart and Engel) and the Laboratory of Developmental Biology and Anomalies (Dr J.-M. Foidart), National Institutes of Health, Bethesda, Md.


Footnotes

Accepted for publication June 9, 1980.

Reprint requests to Center for Neuromuscular Diseases, Department of Neurology, University of Southern California School of Medicine, 2025 Zonal Ave, Los Angeles, CA 90033 (Dr Engel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs
Dell'Agnola et al.
Blood 2004;104:4311-4318.
ABSTRACT | FULL TEXT  

Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
KJAeR
Physiol. Rev. 2004;84:649-698.
ABSTRACT | FULL TEXT  

A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice
Porter et al.
Hum Mol Genet 2002;11:263-272.
ABSTRACT | FULL TEXT  

Acute exercise induced changes in rat skeletal muscle mRNAs and proteins regulating type IV collagen content
Koskinen et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001;280:R1292-R1300.
ABSTRACT | FULL TEXT  

Lysosomal and Nonlysosomal Hydrolases of Skeletal Muscle in Neuromuscular Diseases
Takala et al.
Arch Neurol 1983;40:541-544.
ABSTRACT  

Changes in Collagen Metabolism in Diseased Muscle: I. Biochemical Studies
Myllyla et al.
Arch Neurol 1982;39:752-755.
ABSTRACT  

Changes in Collagen Metabolism in Diseased Muscle: II. Immunohistochemical Studies
Peltonen et al.
Arch Neurol 1982;39:756-759.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.